Press release
United States G-protein Coupled Receptor (GPCR) Targeting Market Insights | Drug Discovery, Therapeutics & Market Analysis
G-protein Coupled Receptor (GPCR) Targeting Market Size
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/g-protein-coupled-receptor-targeting-market?kb
United States: Recent Industry Developments
✅ December 2025: A major U.S. biopharma advanced a next‐generation GPCR‐targeted small molecule into late‐stage clinical trials for metabolic and inflammatory diseases.
✅ November 2025: Research teams reported promising preclinical results for a novel GPCR antibody therapy aimed at CNS disorders, highlighting improved efficacy and safety profiles.
✅ October 2025: Increased venture funding flowed into GPCR‐focused biotech startups developing precision medicines based on receptor sub‐type modulation.
Japan: Recent Industry Developments
✅ December 2025: Japanese pharma companies initiated collaborative R&D with academic centers to accelerate discovery of GPCR modulators for oncology and immunology.
✅ November 2025: Advances were reported in GPCR structural biology platforms, enabling faster drug candidate screening and design.
✅ October 2025: Regulatory discussions progressed on streamlining approval pathways for first‐in‐class GPCR‐targeted therapies, aiming to boost innovation and accessibility.
List of Top Key Player:
Abcam plc, Enzo Life Sciences, Inc, Promega Corporation, PerkinElmer Inc, Thermo Fisher Scientific, Eurofins DiscoverX Products, WuXi AppTec (HD Biosciences Co. Ltd), BioInvenu Inc, Danaher Corporation (Molecular Devices LLC) and Merck KGaA.
Forecast Projection:
The Global G-Protein Coupled Receptor (GPCR) Targeting Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.
Latest M&A
1. Pfizer acquired Metsera for $7.6 billion in Q3 2025, bolstering obesity pipeline with GPCR-targeted assets.
2. Novo Nordisk struck a $1.3 billion AI-based deal with Superluminal Medicines for undisclosed GPCR targets in cardiometabolic/obesity diseases.
3. 2026 pharma M&A outlook highlights obesity (GLP-1/GIP agonists) and HIV, with GPCR central to metabolic deals.
Market Intelligence Research Process:
The G-Protein Coupled Receptor (GPCR) Targeting Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=g-protein-coupled-receptor-targeting-market?kb
Key Segmentation:
By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
By Application Segment: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Respiratory Research, Inflammation Research, Other Application
By End-user: cAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding and GTPγS Functional Assays, Internalization Assays, Trafficking Assays, Other Assays
Growth Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the G-Protein Coupled Receptor (GPCR) Targeting Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.
Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.
Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.
Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.
Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.
Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.
Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.
Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.
Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.
Latest News
✦ Structure Therapeutics (GPCR) priced a $650 million public offering in December 2025 to expand oral small molecule pipeline for metabolic diseases using structure-based discovery.
✦ GPCR Therapeutics out-licensed CXCR4-LPA1 inhibitor combo to Bridge Biotherapeutics (2023, ongoing development); FDA ODD for stem cell mobilization agent
✦ GPCR market trends include biologics/modulators for CNS, oncology; biotech resurgence sets M&A stage
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/g-protein-coupled-receptor-targeting-market?kb
Reimbursement
✦ GLP-1R agonists like semaglutide face coverage hurdles despite efficacy; Medicare/Medicaid/insurance reimburse for approved indications, but out-of-pocket costs common for obesity. Value-based models emphasize long-term outcomes; payers approve rapidly for proven CV/renal benefits
Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States G-protein Coupled Receptor (GPCR) Targeting Market Insights | Drug Discovery, Therapeutics & Market Analysis here
News-ID: 4340693 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Automotive Adhesives and Sealants Market Insights into Materials U …
DataM Intelligence has published a new research report on "Automotive Adhesives and Sealants Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Sample PDF Of This…
Customer Intelligence Platform Market Set for Explosive Growth to USD 14.8 Billi …
The Global Customer Intelligence Platform Market reached USD 2.0 Billion in 2022 and is expected to reach USD 14.8 Billion by 2031, growing with a CAGR of 29.1% during the forecast period 2024-2031.
Market growth is driven by the surging demand for personalized customer experiences, integration of AI and machine learning for deeper insights, and the shift toward data-driven decision-making in businesses. Advancements in real-time analytics, rising adoption of omnichannel strategies,…
Immersion Cooling Market Set for Explosive Growth at 14.3% CAGR Through 2031, Le …
The Immersion Cooling Market is expected to grow at a CAGR of 14.3% during the forecast period 2024-2031.
Market growth is driven by surging demand for energy-efficient data center cooling amid AI and hyperscale computing expansion, rising power densities in high-performance computing (HPC) systems, and sustainability mandates to reduce carbon footprints. Advancements in single-phase and two-phase immersion fluids, adoption by cloud giants like Microsoft and Google, growing investments in edge computing…
Pharmacogenomics market size is estimated to reach US$ 8.87 Billion by 2033, Nor …
The global pharmacogenomics market was valued at US$ 3.59 Billion in 2023. The market size reached US$ 3.92 Billion in 2024 and is expected to reach US$ 8.87 Billion by 2033, growing at a CAGR of 9.8% during the forecast period 2025-2033.
Pharmacogenomics Market Growth is driven by rising demand for personalized medicine, genetic testing advancements, increasing chronic disease prevalence, and the need for safer, more effective drugs tailored to individual…
More Releases for GPCR
United States G-Protein Coupled Receptor (GPCR) Targeting Market 2025 | Growth D …
Market Size and Growth
G-protein Coupled Receptor (GPCR) Targeting Market is Expected to reach at a high CAGR of 6.40% during the forecast period (2024-2031).
Key Development:
United States: Recent Developments in GPCR Targeting
✅ In August 2025, Nxera Pharma announced the launch of an expanded drug discovery pipeline targeting obesity and related metabolic diseases. The company is focusing on a range of validated GPCR targets, building on existing collaborations with Pfizer and…
Revolutionary Growth in G-Protein Coupled Receptor (GPCR) Targeting Market: A $6 …
Market Overview: Unprecedented Expansion in GPCR Technologies
The G-Protein Coupled Receptor (GPCR) targeting market stands as one of the most dynamic and rapidly evolving sectors in biotechnology today. The G-protein coupled receptor (GPCR) targeting market was valued at approximately USD 3.56 billion in 2023 and is anticipated to reach USD 6.88 billion by 2033, growing at a CAGR of 6.4% from 2024 to 2033. This remarkable growth trajectory positions GPCR targeting…
GPCR Assay Market Is Anticipated To Grow In A Promising Manner between 2023-2030 …
The report discusses everything a marketer requires before investing in the global GPCR Assay Market during the forecast period 2023-2030. It provides detailed insight into current trends, market shares, market size, and sales value and volume. The data used for this report is obtained from reliable industry sources, paid resources, and validated sources. This research works as a systematic guideline for marketers to make well-informed decisions.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟…
G-Protein Coupled Receptor (GPCR) Targeting Market Analysis, Size, Share, Curren …
The G-Protein Coupled Receptor (GPCR) Targeting Market report discusses in-depth the growth opportunities, challenges, growth drivers, restraints, threats, and demands of the market. Further, the research assesses the regional market as well as the global market to gather the data into the scope of the G-Protein Coupled Receptor (GPCR) Targeting market. The report also provides estimations and forecasts about the market segment and sub-segments exhibiting favorable growth in the upcoming…
G-Protein Coupled Receptor (GPCR) Targeting Market 2022 | Detailed Report
ReportsnReports publishes the report titled G-Protein Coupled Receptor (GPCR) Targeting that presents a 360-degree overview of the market under one roof. The report is developed with the meticulous efforts of an enthusiastic and experienced team of experts, analyts, and researchers that makes the report a valuable asset for stakeholders to make robust decisions. This report also provides an in-depth overview of product type, specification, technology, and production analysis considering vital…
G-Protein Coupled Receptor (GPCR) Agonist Market 2020 Overview Analysis and Scop …
G-Protein Coupled Receptor (GPCR) Agonist -Pipeline Insight, 2020
The global G-Protein Coupled Receptor (GPCR) Agonist Market research report 2020 provides a basic overview of the industry including definitions, classifications, applications, and industry chain structure. The G-Protein Coupled Receptor (GPCR) Agonist market report provides information regarding market size, share, trends, growth, cost structure, global market competition landscape, market drivers, challenges and opportunity, capacity, revenue, and forecast.
The report delivers a comprehensive overview of…
